FDA.reportPublic FDA data

SODIUM STEARYL FUMARATE

Substance profile for UNII 7CV7WJK4UI, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM STEARYL FUMARATE
Structure render from PubChem CID 23665634

Substance Identity#

UNII
7CV7WJK4UI
Preferred term
SODIUM STEARYL FUMARATE
Registry number
4070-80-8
EC number
223-781-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C22H39O4.Na
Chemical structure for SODIUM STEARYL FUMARATE
Structure render from PubChem CID 23665634

Chemical And Database Identifiers#

InChIKey
STFSJTPVIIDAQX-LTRPLHCISA-M
SMILES
[Na+].CCCCCCCCCCCCCCCCCCOC(=O)\C=C\C([O-])=O
RxCUI
1364936
PubChem
23665634
NCIt
C82292
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound23665634pubchem.ncbi.nlm.nih.gov/compound/23665634
PubChem InChIKey SearchSTFSJTPVIIDAQX-LTRPLHCISA-Mpubchem.ncbi.nlm.nih.gov/#query=STFSJTPVIIDAQX-LTRPLHCISA-M
RxNorm1364936mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1364936
NCI ThesaurusC82292ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82292
FDA Substance Registration System7CV7WJK4UIprecision.fda.gov/uniisearch/srs/unii/7CV7WJK4UI
European Community number223-781-1commonchemistry.cas.org/results?q=223-781-1

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
FENOFIBRATE1
Drug Facts3
Kinray, LLC Omeprazole Drug Facts3
These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19921
Metaxalone Tablets3
ShopRite Omeprazole Delayed Release Tablets 20 mg Drug Facts2
Kmart Corporation Omeprazole Drug Facts4
DZA Brands, LLC Omeprazole Drug Facts4
Harmon Stores Inc. Omeprazole Drug Facts3
Lorazepam1
Drug Facts3
These highlights do not include all the information needed to use Oxcarbazepine safely and effectively. See full prescribing information for Oxcarbazepine Tablets. Oxcarbazepine Tablets Initial U.S. Approval: 200014
These highlights do not include all the information needed to use OXCARBAZEPINE safely and effectively. See full prescribing information for OXCARBAZEPINE tablets. OXCARBAZEPINE tablets, for oral use Initial U.S. Approval: 20001
These highlights do not include all the information needed to use calcium acetate capsules safely and effectively. See full prescribing information for calcium acetate capsules. Calcium Acetate Capsules, 667 mg Initial U.S. Approval: 19901
Baby Teething Plus Tooth Support2
0022ca14-9177-4fe9-90f3-1d67592d8d6c1
These highlights do not include all the information needed to use pravastatin sodium tablets USP safely and effectively. See full prescribing information for pravastatin sodium tablets USP. PRAVASTATIN SODIUM tablets USP for oral use Initial U.S. Approval: 19911
These highlights do not include all the information needed to use Montelukast sodium safely and effectively. See full prescribing information for Montelukast sodium. Montelukast sodium Tablets and Chewable Tablets Initial U.S. approval: 1998 --------- RECENT MAJOR CHANGES --------------- Warnings and Precautions Neuropsychiatric Events (5.4) 03/20131
22c8c913-ee81-4e96-8306-013b44ec0fd42
Fexofenadine HCl and Pseudoephedrine HCI ER Tablets USP 180240 mg1
Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
Oxcarbazepine Tablets1
These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19921
Metaxalone Tablets1
Fluvoxamine Maleate Tablets These highlights do not include all the information needed to use Fluvoxamine Maleate Tablets safely and effectively. See full prescribing information for Fluvoxamine Maleate Tablets. Fluvoxamine Maleate Tablets for oral administration Initial U.S. Approval: 19941
These highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19923
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral use. "Initial U.S. Approval:199220
These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) Tablets Initial U.S. Approval: 20061
Drug Facts1
TRANDOLAPRIL TABLETS 7325 7326 7327 Rx only4
These highlights do not include all the information needed to use valacyclovir hydrochloride tablets safely and effectively. See full prescribing information for valacyclovir hydrochloride tablets. VALACYCLOVIR hydrochloride tablets, film-coated for oral use Initial U.S. Approval: 19951
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral Use INITIAL U.S. APPROVAL: 19925
These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) Film-Coated Tablets, for oral use ISENTRESS ® (raltegravir) Chewable Tablets, for oral use Initial U.S. Approval: 20072
Drug Facts1
Drug Facts1
These highlights do not include all the information needed to use fluvoxamine maleate tablets USP safely and effectively. See full prescribing information for fluvoxamine maleate tablets USP. Fluvoxamine maleate tablets USP, for oral use Initial U.S. Approval: 19944
Drug Facts1
Drug Facts1
Drug Facts1
Drug Facts1
These highlights do not include all the information needed to use pravastatin sodium tablets USP safely and effectively. See full prescribing information for pravastatin sodium tablets USP. PRAVASTATIN SODIUM tablets USP for oral use Initial U.S. Approval: 19911
Drug Facts1
Felodipine ER Tabs2
Drug Facts1
Opana ER 20 mg These highlights do not include all the information needed to use OPANA® ER safely and effectively. See full prescribing information for OPANA® ER. OPANA® ER (oxymorphone hydrochloride) Extended-Release tablets, CII Initial U.S. Approval: 19593
These highlights do not include all the information needed to use OPANA ER safely and effectively. See full prescribing information for OPANA ER. OPANA ER (Oxymorphone Hydrochloride) Extended-Release Tablets, CII Initial U.S. Approval: 2009 ® ® ®2
Omeprazole Delayed Release Tablets, 20 mg3
These highlights do not include all the information needed to use AXERT ® safely and effectively. See full prescribing information for AXERT ® . AXERT (almotriptan malate) Tablets for Oral Use Initial U.S. Approval: 20012
These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
Drug Facts3
Drug Facts1
Drug Facts1
Drug Facts1
Drug Facts1
Drug Facts2
Drug Facts2
Drug Facts1
Drug Facts1
These highlights do not include all the information needed to use valacyclovir hydrochloride tablets safely and effectively. See full prescribing information for valacyclovir hydrochloride tablets. VALACYCLOVIR hydrochloride tablets, film-coated for oral use Initial U.S. Approval: 19951
Drug Facts1
These highlights do not include all the information needed to use Montelukast sodium safely and effectively. See full prescribing information for Montelukast sodium. Montelukast sodium Tablets and Chewable Tablets Initial U.S. approval: 19981
Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
These highlights do not include all the information needed to use ZEGERID safely and effectively. See full prescribing information for ZEGERID. ZEGERID (omeprazole/sodium bicarbonate) Powder for Oral Suspension ZEGERID (omeprazole/sodium bicarbonate) Capsules Initial U.S. Approval: 20041
Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20002
Drug Facts1
These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
16ed3ca8-c85c-4d06-9c4f-d5bbf344b12e1
These highlights do not include all the information needed to use pravastatin sodium tablets USP safely and effectively. See full prescribing information for pravastatin sodium tablets USP. PRAVASTATIN SODIUM tablets USP for oral use Initial U.S. Approval: 19912
MAVIK® (trandolapril tablets)2
TARKA® (trandolapril/verapamil hydrochloride ER tablets)2
These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) Film-Coated Tablets, for oral use ISENTRESS ® (raltegravir) Chewable Tablets, for oral use Initial U.S. Approval: 20072
These highlights do not include all the information needed to use Trilipix safely and effectively. See full prescribing information for Trilipix. Trilipix (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 20081
Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP3
These highlights do not include all the information needed to use Fluvoxamine Maleate Tablets safely and effectively. See full prescribing information for Fluvoxamine Maleate Tablets. Fluvoxamine Maleate Tablets, USP for oral administration Initial U.S. Approval: 19944
Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
5ca97412-1594-4a4e-b5e4-8593ffa1b2422
Prilosec OTC ® omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer1
OPANA ® ER (Oxymorphone Hydrochloride) Extended-Release Tablets 5mg, 10mg, 20mg, and 40mg CII Rx Only1
24f766c1-f92b-4e48-b2f1-9d88b1b1be0c7
These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
ULTRAM ® ER (tramadol HCl) Extended-Release Tablets1
Drug Facts1
Felodipine Extended-Release Tablets, USP Rx only1
These highlights do not include all the information needed to use ACIPHEX safely and effectively. See full prescribing information for ACIPHEX. ACIPHEX (rabeprazole sodium) tablet, delayed release for oral use Initial U.S. Approval: 19992
These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS (raltegravir) Tablets Initial U.S. Approval: 20073
Fexofenadine HCl and Pseudoephedrine HCl5
ad682e7f-e0f5-4f11-8e05-dd308cbf6a051
PRAVASTATIN SODIUM TABLETS Rx only1
These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) Tablets Initial U.S. Approval: 20063
Omeprazole Delayed Release Tablets, 20 mg1
Omeprazole Delayed Release Tablets, 20 mg1
Metoprolol Succinate Extended-Release Tablets, USP 25 mg3
Metoprolol Succinate Extended-Release Tablets, USP 50 mg3
a5ca8004-9a18-4030-a56c-8938c4823c641
Metoprolol Succinate Extended-Release Tablets, USP 100 mg and 200 mg1
b951455c-c235-4e23-9e21-08672d1087262
ea8ce5e2-dad4-4288-a1e1-775ea98a6fb94
ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3925
ULTRAM ER (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3685
JANUVIA (SITAGLIPTIN) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3631
JANUMET (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3630
ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLIES DBA QUALITY CARE PRODUCTS LLC]3607
ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUTCS LLC]3575
OPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3165
KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.]1509
TRILIPIX (FENOFIBRIC ACID) CAPSULE, DELAYED RELEASE [ABBVIE INC.]1459
TARKA (TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ABBVIE INC.]1453
MAVIK (TRANDOLAPRIL) TABLET [ABBVIE INC.]1435
KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
CLARITHROMYCIN TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1003
ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [BRYANT RANCH PREPACK]1001
FENOFIBRATE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
OXCARBAZEPINE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
FELODIPINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
PLENDIL (FELODIPINE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
TOPROL XL (METOPROLOL SUCCINATE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
TOPROL XL (METOPROLOL SUCCINATE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 7CV7WJK4UI page 1 of 1 · 17 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808CAPSULEORAL180 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808CAPSULE, DELAYED RELEASEORAL8.4 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808CAPSULE, EXTENDED RELEASEORAL21 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808GRANULEORAL77 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808GRANULE, FOR SOLUTIONORAL18.2 mg/120ml
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808LOZENGEORAL125 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808PELLETORAL43 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808POWDER, FOR SUSPENSIONORAL3.74 mg/5ml
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLETORAL153 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, CHEWABLEORAL28 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, COATEDORAL1.18 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, DELAYED RELEASEORAL216 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, EXTENDED RELEASEORAL42 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, FILM COATEDORAL98 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, FOR SUSPENSIONORAL435 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, ORALLY DISINTEGRATINGORAL153 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLETSUBLINGUAL29 mg